Table 2.

Characteristics of stroke recurrence in included trials.

Study	Stroke type, n		Treatment		Region of China	Comorbidity
	Ischemic	Hemorrhagic	Agent	Dosage (Mean, mg/d)
Yan and Zhang (20)	20	ns	Atorvastatin	20	Northern	Diabetes, hypertension
Lin et al. (18)	100	ns	Fluvastatin	40	Southern	Diabetes, hypertension
Zhao et al. (21)	143	47	Statins	na	Northern	Hypertension, dyslipidemia
Wang et al. (19)	1,062	ns	Pitavastatin	2	Northern	Diabetes, hypertension, dyslipidemia, carotid artery stenosis
			Rosuvastatin	9.8
			Atorvastatin	18.5
			Lovastatin	20.5
			Pravastatin	23.5
Zhao et al. (22)	53	ns	statins	na	Northern	Diabetes, hypertension, coronary heart disease, atrial fibrillation

na, not available; ns, not specified.